Use of nanodispersions in pharmaceutical end formulations

US7081253B2 · kind B2 · utility

Assignees

• Ciba Specialty Chemicals Corporation · US
• Vesifact AG · CH

Inventors

• Andreas Supersaxo · Baar, CH
• Hans Georg Weder · Thalwil, CH
• Dietmar Huglin · Eimeldingen, DE
• Joachim Roding · Wiesbaden, DE

Key dates

• Filing date: May 6, 1999
• Grant date: Jul 25, 2006
• Expiry date: May 6, 2019

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P17/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A description is given of the use of a nanodispersion, which comprises The nanodispersions used according to this invention are suitable as transport vehicles for pharmaceutical active agents.